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Case history
A Japanese boy was born at 41 weeks of gestational age by
spontaneous cephalic delivery, with birth weight 3,680g.
Family history was remarkable for his elderly sister suffer-
ing from classic Bartter syndrome. He also was diagnosed
as classic Bartter syndrome, based on the findings such as
failure to thrive, metabolic alkalosis with hypokalemia, and
the activated renin-aldosterone system. The diagnosis was
later confirmed by CLCNKB gene analysis which revealed
compound heterozygous mutations: deletion of the exon
1 - 3 (derived from his mother) and ΔL130 (derived from
the father). Treatment with spironolactone, indomethacin,
sodium chloride, and potassium supplementation was
commenced at 8 months of age. However, his serum
potassium level failed to normalize, and tended to be
around 2 - 3mEq/L. He had mild intellectual impairment,
and needed specialized education. When he was 11 years
old, through the investigation for macrohematuria, renal
stones with nephrocalcinosis were detected. This compli-
cation resolved following the amelioration of hypokalemia,
which was achieved by vigorous potassium fortification.
Because his growth rate was consistently subnormal and
he was very short (-4.7SD), scrutiny for growth hormone
(GH) secretion was conducted at his 14 years of age.
Results
Profound GH deficiency was evident. Serum IGF-1 level
was 80ng/mL (norm, 178-686), with IGFBP-3 1.92μg/mL
(2.69-4.16). Pharmacologically stimulated GH levels were
0.15 and 0.39 ng/mL, after insulin and arginine adminis-
tration, respectively. His bone age was 11.4 years old
(TW2-RUS for Japanese). MR imaging detected no
abnormality within hypothalamic-pituitary region.
Clinical course
GH treatment with 0.15-0.19mg/kg/week resulted in
growth rate as much as 11.7cm during the first 12-months,
followed by 10.8cm during the subsequent 12 months.
Although his pubertal stage progressed from Tanner stage
1 to stage 2 during 2 years, Δ bone age / Δ chronological
age was 1.02. No significant change in serum potassium
level was observed.
Discussion
In literature, GH deficiency in Bartter syndrome and
Gitelman syndrome has been anecdotally reported, with
diverse severity among patients. At present, its precise
pathogenesis, as well as its prevalence, is unknown.
Classic Bartter syndrome complicated with profound
GH deficiency, as seen in this case, is rare. The sister of
the case, who also suffered from classic Bartter syn-
drome, is 145 cm tall (-2.0SD) now and seemed not to
be GH deficient. Her potassium level had been managed
rather better than this case. It may be tempting to spec-
ulate that long-term hypokalemia may be harmful for
somatotrophs to produce GH.
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